Media News

SeekIn Receives CE-IVD Mark Approval for PanCanSeek® Cancer Mutation Detection Kit

First-of-its-kind one-for-all cancer mutation detection test SHENZHEN, China, Dec. 19, 2022 /PRNewswire/ -- SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (Conformité Européenne) Mark approval for PanCanSeek® Cancer Mutation Detection Kit and is now ready to launch this test in European Union and other countries that recognize CE-IVD Mark. Cancer is a...

China and ASEAN Deepened Exchanges and Cooperation on Traditional Medicine

BEIJING, Dec. 19, 2022 /PRNewswire/ -- A report from CRIOnline: From December 11 to 13, the 7th China-ASEAN Forum on Traditional Medicine was held in Fangchenggang City, Guangxi, China. China-ASEAN Forum on Traditional Medicine is held every two years. With the theme of "Seizing RCEP Opportunities to Promote High-quality Development of Traditional Medicine", the 7th Forum held discussions focused...

GenFleet Therapeutics and Merck Enter into Trial Collaboration to Initiate Study Investigating Combination Therapy of GFH925 (KRAS G12C inhibitor) and ERBITUX® (cetuximab)

SHANGHAI, Dec. 19, 2022 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced that it has entered into a clinical trial collaboration and supply agreement with Merck to start a clinical study of the combination therapy of GFH925 with ERBITUX® (cetuximab) as a potential frontline treatment among NSCLC patients harboring KRAS...

Ascletis Announces Notice of Issuance of the U.S. Patent for Oral Viral Polymerase Inhibitor ASC10 and Its Derivatives

--The issue date of the patent will be January 3, 2023 by the United States Patent and Trademark Office (USPTO). The patent number is 11,541,071 -- The issued patent covers ASC10 and its derivatives, and their uses to treat virus infections including SARS-CoV-2, monkeypox virus and respiratory syncytial virus (RSV) -- Ascletis is the first Chinese biotech company...

Magnetic Resonance Imaging Market to Witness Growth Due to The Increasing Demand for Scans

The prevalence of cardiovascular and oncology diseases and the shortage of radiologists have boosted the development of innovative MRI technologies SAN ANTONIO, Dec. 19, 2022 /PRNewswire/ -- The traditional magnetic resonance imaging (MRI) approach is being disrupted by portable MRI systems, open design MRI systems, advanced metamaterials, and integration of artificial intelligence (AI) and advanced software technologies. The rising...

SmartFuture Launches First Responder Platform

SINGAPORE, Dec. 19, 2022 /PRNewswire/ -- As a key addition to its portfolio of Remote Patient Monitoring (RPM) solutions, SmartFuture has launched a First Responder Platform. This is an integrated solution designed for rapid response through real time monitoring of health vitals, doctor consultation and timely action during emergency situations. The Platform consists of (a) a First Responder Kit consisting...

Clinical Trial Approval For The Company’s Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines

TAIZHOU, China, Dec. 19, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that, the Group has recently received the clinical trial approval for its novel adjuvanted recombinant shingles vaccine, REC610, from the Food and Drug Administration of the Philippines....

Mahidol University Created VR Contents for Teaching Skills of Infectious Disease Treatment and Held a Remote VR Seminar for Japanese Medical Students Connecting Thailand and Japan

Collaborative Development of Infectious Disease Education VR with Jolly Good and Juntendo University TOKYO, Dec. 19, 2022 /PRNewswire/ -- Jolly Good Inc. (Chuo-ku, Tokyo, CEO: Kensuke Joji, hereinafter referred to as "Jolly Good") held a bilateral medical VR seminar connecting Thailand and Japan at JITMM 2022, an international medical conference, utilizing VR teaching materials (*) developed in collaboration with Royal...

‘NCDs in Focus Act Now’ Summit organized by Viatris

The summit aimed to build synergies between healthcare professions and policy makers, addressing the challenges in the management of NCDs in Southeast Asia BANGKOK, Dec. 19, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS): The 'NCDs in Focus Act Now' Summit was recently organised by global healthcare company, Viatris, in collaboration with the...

Education Cannot Wait Receives Mother Teresa Memorial Award for Social Justice 2022

"On behalf of the 222 million crisis-affected girls and boys worldwide who urgently need education support, I am honored and humbled to accept the Mother Teresa Memorial Award for Social Justice." – ECW Director Yasmine Sherif MUMBAI, India, Dec. 18, 2022 /PRNewswire/ -- The Harmony Foundation awarded Education Cannot Wait – the United Nations...